Key Takeaways
- A brutal year, capped by a structural reset: FY26 revenue fell to INR4,224 crores with EBITDA of just INR198 crores, and the quarter ended with an INR898 crore impairment on the suspension PVC investment, signaling management’s view that the earnings outlook has structurally deteriorated.
- Specialty is the lone bright spot: The specialty segment posted one of its strongest quarters at INR475 crores, up 13% YoY, with paste PVC volumes up 17% and the Cuddalore facility running at full capacity.
- Suspension PVC is now a breakeven business: Chinese carbide PVC flooding India post the Middle East war has broken the link between PVC and feedstock VCM prices, leaving CCVL just covering variable costs with no near-term regulatory fix in sight.
- A board committee will now review everything: Three independent directors have been tasked with examining strategic priorities, including potential reorganization and M&A, a clean-slate mandate that signals the status quo is untenable.
- What to watch next quarter: Whether the 7.5% customs duty on PVC actually returns at end-June, any progress on the antidumping duty filing against Chinese SPVC, and the pace of R32 refrigerant gas commercialization.
The Suspension PVC Crisis
- How the business broke: The Middle East war created an acute shortage of naphtha and ethylene, spiking VCM feedstock prices. PVC prices initially rose in sympathy but collapsed when Chinese carbide-based PVC, immune to the war’s feedstock impact, flooded India at very low prices. The result is a sharp, persistent disconnect between PVC realizations and feedstock costs.
- Current economics: On a replacement cost basis, spreads are neutral, meaning the business is effectively just meeting variable cost after accounting for conversion. Management expects CCVL to remain around breakeven at least until the geopolitical situation improves post June.
- The impairment: An INR898 crore non-cash impairment was taken against a book value of INR1,556 crores on the CCVL investment, reflecting a structural reset in earnings outlook. A separate INR150 crore exceptional charge for onerous contracts and raw material write-downs is expected to reverse in Q1 FY27, though one or two more consignments may still see some contribution difference.
- Regulatory relief is stalled: The industry had expected antidumping duties, higher customs duty, or other import controls. None materialized. Quality Control Orders were rescinded and customs duty was reduced, though only until June 2026. Management calls ADD the only long-term WTO-compliant solution and is preparing a fresh filing against Chinese imports in the near future.
- Demand is not the problem yet: Domestic SPVC demand was muted in FY26, down about 1 percentage point, but management expects it to catch up once the geopolitical situation settles, taking 1-2 quarters. PVC consumption tends to track GDP growth, and construction activity is not expected to reverse on diesel price hikes.
Ganeshkumar: "the antidumping duty is the only long-term solution, which is compliant with the WTO."
Specialty: Paste PVC and CMC
- Paste PVC is delivering: The Cuddalore facility operated at 100% capacity through the year, with realizations and margins seeing a steady uptick in Q4. Demand from footwear was stable, while automotive and upholstery segments continued healthy traction.
- The ADD catalyst: Final findings from the DGTR’s antidumping investigation against paste PVC imports from the EU and Japan have been received, with notification by the Finance Minister expected during H1 FY27. Implementation would provide a further margin tailwind.
- CMC is behind but building: Revenue was impacted by a global agrochemical slowdown, pricing pressure from Chinese generics, and slower ramp-up of new molecules by innovators. Management now says the INR1,000 crore revenue target is running about 12 months behind, with achievement anticipated in FY27.
- The pipeline supports the target: The order book for FY27 is described as strong, with 45-plus molecules in the pipeline. Customer engagement is intensifying, and innovators continue to indicate intent to diversify their supplier base into India, viewing Chemplast as a reliable partner. Senior business development resources have been recruited in Europe, with engagement also ramping up in Japan.
- Diversification beyond agchem: The medium-to-long-term initiative to diversify CMC’s end-market exposure is underway, though no specific timeline was given.
Rangachari: "the engagement with all our customers is quite strong. And all of them continue to indicate an intent to diversify their supplier base in India. And when they look for reliable good partners, they continue to consider Sanmar as a very reliable partner." [8-9]
Refrigerant Gases: The New Growth Vector
- R32 production has begun: Commercial production of R32 refrigerant gas at the 2 kt swing plant in Mettur commenced recently. New plants are expected to be commissioned in phases over the course of the year, reaching 14 kt capacity by end of calendar year, with design provisions to debottleneck further.
- Go-to-market is taking shape: The strategy combines domestic and export sales. Management is working with a few partners for export market access and is confident of cracking this, though no agreements have been finalized.
- Hydrofluoric acid sourcing is secured short-term: Tied up with a couple of sources to meet near-term demand. As the business scales and generates profitable contribution, backward integration into own support systems becomes an option. Logistics for the full 14 kt are still being arranged.
- Vietnam quota is a belief, not a guarantee: The entire industry is operating on the assumption that Vietnam will grant R32 quotas under the Kigali Amendment. The baseline survey period runs through end of 2026, with clarity expected by 2027. Management strongly believes Chemplast should receive quota and has rights to some volumes, but the government is still working on it.
- Chloromethanes integration: Existing chloromethanes capacity is sufficient to supply the R32 plant’s feedstock needs.
Caustic Soda and Chloromethanes
- A weak year with a temporary spike: Caustic soda and chloromethanes markets were under pressure for most of FY26 on weak demand and pricing. A temporary spurt in caustic prices followed the Middle East war but is now tempering back toward the normal levels of the last couple of years.
- Volumes were constrained by maintenance: Caustic soda volumes improved sequentially in Q4 on better sales and inventory liquidation at Karaikal, but were lower YoY due to reduced production at Mettur during a membrane change activity. Hydrogen peroxide and chloromethanes volumes were also impacted by lower hydrogen and chlorine availability linked to the reduced caustic output.
- End-user demand is stable: Demand from key end-user industries and pharma customers remained largely stable through the quarter.
The Strategic Review
- A committee with a clean slate: The board constituted a committee of three independent directors to examine strategic priorities for enhancing long-term value creation. The mandate includes evaluating potential reorganization and M&A opportunities, and the committee may engage external advisers.
- What it signals: Management framed this as a holistic look at the business portfolio to determine how best to reorganize and unlock value for all stakeholders. No specific mandate beyond that has been given, and it is too premature to prejudge whether a restructuring will occur.
- Capital allocation context: Specialty has been and will remain the priority for capital allocation: paste PVC expansion, custom manufacturing, and refrigerant gases. The committee’s work sits alongside this, not as a replacement for it.
Muralidharan: "Given that, we thought it is important that we look at the business as a whole and see how best we can reorganize the business going forward and create value -- unlock value for all the stakeholders. That's the broad objective. And that's the mandate. Beyond that, we have not given any mandate to the company."
The China Problem and Regulatory Pathway
- The structural asymmetry: Chinese carbide-based PVC is produced using coal, insulating it from the naphtha and ethylene price spikes that hit India’s VCM-based producers. When the Middle East war disrupted global feedstock supply, Chinese exporters exploited the window to flood India at prices Indian producers cannot match.
- China’s own anti-involution drive: The 13% export rebate removal briefly improved profitability in January and February, but that benefit was completely subsumed by the post-war market dislocation. Management sees no impact of that spread in current margins.
- The regulatory toolkit: The 7.5% customs duty on PVC is assumed to return at end-June 2026, adding an estimated $60-$70 per tonne to Chinese import pricing. Beyond that, management is pursuing ADD (a fresh filing against China in the near future), minimum import price, and the reinstatement of QCOs, arguing the government cannot paint all products with the same brush.
- The reality check: On pessimistic assumptions, FY27 could remain stressful for CCVL even if Chinese producers are themselves under cost pressure. Management acknowledged this possibility but noted that the true situation inside China is opaque.
Ganeshkumar: "China factual situation is always a mystery, whatever we can discuss. But at the end of the day, we will never be able to know the real situation what's happening there. Rather, we should focus on... our government, our regulatory system and make sure that we get the adequate protection or rather protection is not the right word, the adequate support to bring us on a level playing field."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Paste PVC ADD implementation | Final DGTR findings received; notification by Finance Minister expected | H1 FY27 |
| CMC revenue target | INR1,000 crores; management says they "stand a good chance of getting there" | FY27 |
| R32 capacity | 14 kt capacity online | End of calendar year |
| Customs duty on PVC | 7.5% duty expected to return (assuming no extension) | End of June 2026 |
| SPVC ADD filing | Fresh filing for ADD on imports from China | "Near future" |
| CCVL exceptional item reversal | INR150 crore charge expected to reverse | Q1 FY27 |
| SPVC CCVL near-term performance | Around breakeven until geopolitical situation improves | Until post-June |
| R32 Vietnam quota clarity | Baseline survey period ends; quota allocation clarity expected | By 2027 |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue | ₹1,256 cr, 9% YoY growth |
| Consolidated EBITDA | ₹194 cr, vs ₹37 cr in Q4 FY25 |
| Consolidated net loss | ₹45 cr |
| Specialty Chemicals segment revenue | ₹475 cr, 13% YoY growth; volumes up 17% YoY |
| Value-added Chemicals segment revenue | ₹120 cr, vs ₹169 cr in Q4 FY25 |
| Suspension PVC (CCVL) segment revenue | ₹661 cr, 18% YoY growth vs ₹560 cr in Q4 FY25 |
| Revenue mix | Specialty 38%, Value-added 9%, Suspension PVC 53% |
| Consolidated FY26 revenue | ₹4,224 cr |
| Consolidated FY26 EBITDA | ₹198 cr |
| Consolidated FY26 net loss | ₹280 cr |
| Consolidated net debt | ₹1,419 cr as of March 31, 2026 |
| Impairment loss on investment in CCVL | ₹898 cr exceptional item, vs book value of ₹1,556 cr |
| CCVL exceptional item (onerous contracts, inventory write-down) | ₹150 cr charge for FY26, expected to reverse in FY27 |
| Paste PVC capacity utilization (Cuddalore) | 100% through FY26 |
| CMC pipeline | 45-plus molecules across development stages, 17 commercial |
| R32 refrigerant gas capacity | 2 kt swing plant commenced production; 14 kt target by end of calendar year |
| SPVC domestic demand (FY26) | ~0.43 cr tons, about 1 ppt below FY25 |
| Chinese PVC price (CFR India) | $820 per ton |
| FOB Japan VCM price | $755–$760 per ton |